| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 33.69▲ | 33.50▲ | 33.53▲ | 33.66▲ | 33.27▲ |
| MA10 | 33.59▲ | 33.38▲ | 33.36▲ | 33.25▲ | 31.76▲ |
| MA20 | 33.47▲ | 33.25▲ | 33.61▲ | 33.52▲ | 28.72▲ |
| MA50 | 33.39▲ | 33.52▲ | 33.16▲ | 31.82▲ | 25.93▲ |
| MA100 | 33.32▲ | 33.05▲ | 33.40▲ | 28.74▲ | 26.95▲ |
| MA200 | 33.55▲ | 33.49▲ | 32.93▲ | 26.83▲ | 31.23▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.046▲ | 0.067▲ | 0.009▲ | -0.098▼ | 0.522▲ |
| RSI | 71.406▲ | 61.405▲ | 58.368▲ | 56.830▲ | 64.915▲ |
| STOCH | 82.187▲ | 59.302 | 45.422 | 57.276 | 76.553 |
| WILL %R | 0.000▲ | -30.909 | -26.984 | -29.909 | -13.522▲ |
| CCI | 239.425▲ | 166.485▲ | 131.121▲ | 52.326 | 86.177 |
|
Friday, May 08, 2026 07:02 AM
Enrollment completed six months ahead of guidance in both barzolvolimab Phase 3 chronic spontaneous urticaria studies (EMBARQ-CSU 1 and 2); ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 34.94 | 34.94 | 32.62 | 33.97 | 731,634 |
| 07/05/26 | 34.25 | 34.25 | 32.63 | 33.32 | 859,490 |
| 06/05/26 | 33.91 | 34.54 | 33.33 | 34.39 | 534,758 |
| 05/05/26 | 33.13 | 34.20 | 32.43 | 33.86 | 717,134 |
| 04/05/26 | 32.17 | 33.01 | 32.17 | 32.77 | 462,308 |
| 01/05/26 | 32.90 | 33.86 | 32.17 | 32.31 | 312,975 |
| 30/04/26 | 32.70 | 33.315 | 32.29 | 32.88 | 497,311 |
| 29/04/26 | 32.73 | 32.99 | 31.65 | 32.14 | 602,763 |
| 28/04/26 | 33.96 | 34.53 | 33.19 | 33.23 | 742,242 |
| 27/04/26 | 33.15 | 34.50 | 33.15 | 33.66 | 824,844 |
|
|
||||
|
|
||||
|
|